Brazil's state-run Oswaldo Cruz Foundation (Fiocruz) has developed two types of polymerase chain reaction (PCR) tests to detect the monkeypox virus, a disease that has left more than 2,000 cases in the South American country, the institution announced today.
Fiocruz applied to the National Health regulator (Anvisa) for registration of the two molecular tests to detect the disease.
One PCR test allows the identification of viral DNA in samples of skin rashes present in the person with a suspected infection.
The other is used for differential diagnosis, ruling out other possibilities of diagnosis by related viruses.
Two . . .